Apollo Hospitals Hits Record High After Board Clears Listing Plan

rallied up to 4.7% on July 1, 2025, hitting a fresh all-time high of ₹7,584.50 after the board approved the separate listing of its omni-channel pharmacy and digital health businesses. The move, expected to be executed within 18–21 months, is part of a broader value unlocking strategy. Established in 1983 by Dr. Prathap C Reddy, Apollo is a leading integrated healthcare provider across Asia, offering hospitals, pharmacies, telemedicine, and more. Notably, ₹7,545 was acting as a key resistance level, and although prices briefly breached this mark, they retraced to trade near ₹7,500 by mid-session today. As of July 2, prices are trading flat, hovering around yesterday’s closing, indicating some consolidation post the sharp move. Year-to-date, the stock has gained approximately 3% in CY25. The rally reflects strong investor optimism about the strategic realignment of Apollo HealthCo. At ₹7,500, the stock trades at a PE of 72.02, well above the sector average, it may indicate high growth expectations amid reorganisation. Key support levels are placed at ₹6,750 and ₹6,594. Disclaimer: This post is intended solely for informational purposes and should not be construed as a recommendation to buy, sell, or hold any security. Investors are advised to consult their certified financial advisor before making any investment decisions. Artificial Intelligence tools may have been used to assist in preparing parts of this content, including drafting and data structuring. Investments in the securities market are subject to market risks. Please read all relevant offer documents and disclosures carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide assurance of returns to investors. The securities and charts quoted herein, if any, are purely illustrative and are not to be interpreted as recommendatory. Past performance is not indicative of future results.